|
Market Closed -
NYSE
00:03:33 26/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 264.34 USD | -0.29% |
|
+0.14% | +15.69% |
| 02:01am | US FDA approves AbbVie's drug for Parkinson's disease | RE |
| 09-25 | ADARx Pharmaceuticals shares soar in Nasdaq debut after upsized IPO | RE |
| Market Cap | 467B 410B 387B 353B 660B 44,771B 665B 4,633B 1,794B 22,873B 1,754B 1,716B 73,510B | P/E 2026 * |
33.4x | P/E 2027 * | 24.9x |
|---|---|---|---|---|---|
| Enterprise Value | 529B 464B 438B 399B 748B 50,674B 753B 5,243B 2,031B 25,888B 1,985B 1,942B 83,203B | EV / Sales 2026 * |
7.82x | EV / Sales 2027 * | 7.08x |
| Free-Float |
95.71% | Yield 2026 * |
2.59% | Yield 2027 * | 2.73% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABBV | Delayed | |
CBOE
| ABBV | Real-time | |
|
Tradegate
| 4AB | Real-time | |
|
Mexican S.E.
| ABBV * | End-of-day quote | |
|
Boerse Muenchen
| 4AB | Real-time | |
|
Borsa Italiana
| 1ABBV | End-of-day quote | |
|
Xetra
| 4AB | Delayed | |
|
London S.E.
| 0QCV | Delayed | |
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| 4AB | Delayed | |
|
Börse Stuttgart
| 4AB | Delayed | |
|
Swiss Exchange
| ABBV | Delayed | |
|
Wiener Boerse
| ABBV | End-of-day quote | |
|
CBOE
| 0QCV | Real-time | |
|
Santiago S.E.
| ABBV | End-of-day quote | |
|
Santiago S.E.
| ABBVCL | End-of-day quote | |
|
Swiss Exchange
| ABBV | Delayed |
Last Transcript: AbbVie Inc.
| 1 day | -0.29% | ||
| 1 week | +0.14% | ||
| Current month | +3.09% | ||
| 1 month | -0.55% | ||
| 3 months | +8.72% | ||
| 6 months | +27.59% | ||
| Current year | +15.69% |
| 1 week | 261.23 |  | 269.39 |
| 1 month | 246.77 | | 269.39 |
| Current year | 190.75 | | 269.39 |
| 1 year | 190.75 | | 269.39 |
| 3 years | 135.85 | | 269.39 |
| 5 years | 106.86 | | 269.39 |
| 10 years | 55.06 | | 269.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 01/07/2024 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 23/06/2022 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 01/01/2013 |
William Burnside
BRD | Director/Board Member | 74 | 01/01/2013 |
Ed Rapp
BRD | Director/Board Member | 69 | 01/01/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/08/26 | Exercice | Executive/Senior Manager | 98,130 | 0.0056% | ||
| 30/06/26 | Free | Director | 62 | 0.0000% | ||
| 30/06/26 | Free | Director | 134 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.29% | +0.14% | +20.96% | +70.93% | 467B | |
| +0.13% | +2.65% | +65.61% | +114.28% | 1,055B | |
| +0.20% | +0.46% | +52.60% | +69.24% | 654B | |
| -0.85% | +0.98% | +41.29% | +44.38% | 348B | |
| +0.71% | +4.08% | +22.24% | +29.51% | 275B | |
| +1.23% | +0.42% | +14.57% | +12.13% | 258B | |
| +2.11% | +7.51% | +52.89% | +55.37% | 224B | |
| +0.83% | +0.55% | +35.99% | +101.70% | 187B | |
| 0.00% | -10.14% | -29.94% | -60.30% | 171B | |
| +0.92% | +3.65% | +21.48% | -13.07% | 163B | |
| Average | +0.33% | +1.03% | +29.77% | +42.42% | 380.18B | |
| Weighted average by Cap. | +0.03% | +1.42% | +40.67% | +64.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.59B 59.31B 56.01B 51.05B 95.56B 6,478B 96.24B 670B 260B 3,309B 254B 248B 10,636B | 73.49B 64.49B 60.91B 55.5B 104B 7,044B 105B 729B 282B 3,598B 276B 270B 11,565B |
| Net income | 14.08B 12.35B 11.67B 10.63B 19.91B 1,349B 20.05B 140B 54.08B 689B 52.86B 51.72B 2,216B | 19.09B 16.75B 15.82B 14.42B 26.99B 1,829B 27.18B 189B 73.32B 935B 71.67B 70.12B 3,004B |
| Net Debt | 61.59B 54.05B 51.05B 46.52B 87.08B 5,903B 87.7B 611B 237B 3,016B 231B 226B 9,693B | 53.09B 46.59B 44B 40.1B 75.06B 5,089B 75.6B 527B 204B 2,600B 199B 195B 8,355B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | $264.34 | -0.29% | 2,541,718 |
| 24/09/26 | $265.12 | +0.02% | 3,458,166 |
| 23/09/26 | $265.08 | -0.05% | 3,469,242 |
| 22/09/26 | $265.21 | +0.28% | 2,766,286 |
| 21/09/26 | $264.48 | +0.20% | 3,438,150 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
Select your edition
All financial news and data tailored to specific country editions
